We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Theravance Biopharma Inc | NASDAQ:TBPH | NASDAQ | Common Stock |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
8.81 | 9.48 | 9.27 | 9.06 | 9.13 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 57.42M | -55.19M | -1.1459 | -7.97 | 439.74M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
21:13:44 | 17 | 9.12 | USD |
Date | Time | Source | Headline |
---|---|---|---|
09/5/2023 | 23:58 | DJN | Theravance Says FDA Grants Orphan Drug Designation Status to Ampreloxetine |
Theravance Biopharma (TBPH) Share Charts1 Year Theravance Biopharma Chart |
|
1 Month Theravance Biopharma Chart |
Intraday Theravance Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions